Good Optical Services

Novatears by AFT Pharmaceuticals is a preservative-free, phosphate-free, water-free, osmolarity-free, and steroid-free formulation of 100% perfluorohexyloctane to treat the symptoms of dry eye disease (DED).

Perfluorohexyloctane has a unique molecular structure that effectively inhibits tear film evaporation,1-3 likely by acting as a functional substitute for the tear film lipid layer. Given that lipid layer deficiency and associated evaporative dry eye are key contributors in the majority of DED cases,4-6 Novatears offers a targeted approach to the number one cause of DED.

Across three Phase 3 trials,7-9 Novatears produced meaningful, consistent reductions in both signs and symptoms of DED as early as week one, with sustained efficacy through 52 weeks. Statistically significant and clinically meaningful reductions in the severity and frequency of DED symptoms were observed as early as the third day of treatment.

In a Phase 4 trial,10 Novatears provided immediate symptom relief after a single instillation, with significant reductions in symptom severity and frequency over two weeks.

Contact: Good Optical (AUS) 03 9645-1066 or visit goodopticalservices.com.au.

Your patients can experience soothing hydration and lasting relief for dry, tired, and irritated eyes with Blink Intensive Tears. These advanced, preservative-free eye drops act as artificial tears, replenishing the eyes’ natural moisture while forming a protective, hydrating barrier to ease redness, irritation, and grittiness caused by mild-to-moderate dry eye.

Formulated with a high dose of hyaluronic acid (0.2%), Blink Intensive Tears delivers superior hydration and comfort to the ocular surface.* These soothing eye drops are safe for use with contact lenses – there is no need to remove them.

Contact: Bausch and Lomb Territory Manager or (AUS) 1800 251 150

Idra and Activa provide a comprehensive approach to diagnosing and managing dry eye disease.

Idra is a fast non-invasive ocular surface analyser that evaluates all tear-film layers, including lipid interferometry, non-invasive tear break-up time (NIBUT), meibography, tear meniscus height, blink analysis, and high-resolution lid and ocular imaging – all in just 15 seconds per eye.

Activa complements this by delivering targeted therapy, applying controlled heat at 42°C with gentle micro-vibrations to melt thickened meibum and restore natural lipid flow, stabilising the tear film.

Together, these solutions allow clinicians to implement personalised, evidence-based treatment strategies, enhance patient understanding, and provide safe, effective relief from dry eye symptoms.

Contact: BOC Instruments (AUS) 02 9643 7888 or visit bocinstruments.com.au.

Topcon Myah is an all-in-one platform for myopia management and anterior segment assessment. Combining optical biometry, corneal topography, pupillometry, and dry eye diagnostics, it provides accurate axial length measurements with trend analysis and built in growth curves to support early myopia risk evaluation in children. Myah’s corneal topography also includes keratoconus screening and delivers key insights for lens fitting and visual quality assessment.

Myah’s comprehensive dry eye suite offers non-invasive break-up time (NIBUT), tear meniscus height measurement, meibomian gland imaging, and blink analysis. With rapid, patient-friendly data capture and integrated reporting, it streamlines workflow, enhances diagnostic accuracy, and supports confident clinical decisions.

Contact: Device Technologies Account Manager or email eyes@device.com.au

Rexon-Eye uses QMR (quantum molecular resonance) technology to deliver controlled, low-intensity, high-frequency electrical fields that stimulate cellular metabolism without thermal damage. Clinical studies report up to 45% improvement in tear break-up time and significant reductions in ocular surface disease index (OSDI) scores after a simple treatment protocol of six 20-minute sessions over six weeks.1-2

According to Eyetek, evidence also indicates enhanced goblet cell density and improved meibomian gland function, supporting restoration of ocular surface homeostasis rather than temporary symptom relief.1-2

The procedure is non-invasive, well tolerated, and integrates easily into clinical workflow without ongoing consumable costs.

Visit: eyetek.com.au

Albomed Pe-Ha Guard HPMC 2.0% corneal lubricant is easy to use and highly effective in protecting the corneal epithelium following anaesthesia and during ophthalmic procedures such as cataract, vitreoretinal, and glaucoma surgery. Albomed Pe-Ha Guard may increase the safety of surgery as it can significantly improve the clarity of the corneas, which helps with optimising the surgical view.

Other advantages include greater workflow efficiency as it frees up the scrub nurse from frequently applying balanced salt solution intraoperatively. Studies have shown improved patient comfort postoperatively as it significantly reduces dry eye issues/corneal epithelium issues after surgery.1,2 It may also help with ensuring patient satisfaction and achieving precise outcomes in the early postoperative period – particularly with multifocal intraocular lens patients.

Contact: SurgiVision (AUS) 1300 995 132 or sales@surgivision.com.au

DryEye Forte is a patented, advanced oral supplement that provides systemic dry eye relief and anti-inflammatory support. This comprehensive, evidence-based formula combines therapeutic levels of EPA and DHA from re-esterified pharmaceutical grade fish oil (mercury-tested and sustainably sourced) and GLA from plant-based borage oil, delivering a formula rich in essential fatty acids.1

Vitamin D3 and vitamin E provide strong anti-inflammatory and antioxidant support. DryEye Forte optimises the production of anti-inflammatory prostaglandins, reduces ocular inflammation, and restores a healthy tear film.

This product is not sold in pharmacy. Samples and information about wholesale deals are available on request.

Contact: MD EyeCare (AUS) 1300 952 001 or (NZ) 0800 443 652

Rohto Dry Aid is a clinically proven, microemulsion formulation designed to address the three layers of the tear film:

Mucoaqueous stabilisation. Povidone enhances hydration and reduces friction.
Lipid supplementation. Sesame and castor oils contribute polar and non-polar lipids, helping reduce evaporation.

Improved spread and stability. Polyoxyl-40 stearate supports tear-film layering and distribution.

Neurosensory relief. Menthol acts on TRPM8 channels, stimulating basal tearing and providing a cooling, soothing sensation.

Tearshield Technology, a unique lipid enhancing formulation, is particularly effective for evaporative dry eye. Rohto Dry Aid provides patients with immediate and long-lasting relief (up to 12 hours) from eight common dry eye symptoms, every day.

Contact: Ophthalmopro (AUS) 1300 578 288 or orders@ophthalmopro.com.au

Lacritec, as a systemic approach to dry eye treatment, is ideally placed to augment other dry eye treatments and provide superior outcomes. According to Stiltec, “Lacritec uniquely combines the benefits of concentrated fish oil, borage oil, and the proven and professionally researched flax seed oil”.

The physiological and nutrigenomic benefits of alpha-linolenic acid (ALA), which is derived from flax seed oil, result in a systemic lowering of inflammatory cytokines and prostaglandins that have been directly associated with dry eye symptoms. Specifically, Stiltec said the studies showing the effect ALA has on interleukin 6 and prostaglandin E2 highlight the unique benefit flaxseed oil provides in the treatment for dry eye disease, Stiltec said.

Contact: Stiltec (AUS)1800 622 883 or visit stiltec.com.au

The Topcon Tera combines advanced Placido-based corneal topography with a comprehensive dry eye suite, designed to support confident evaluation and management of ocular surface disease in ophthalmology, optometry, and speciality clinics. Tera helps eye care professionals identify the underlying drivers of dry eye and ocular surface disease. Aligned with TFOS DEWS III recommendations, its non-invasive assessments – including tear meniscus height (TMH), non-invasive tear break-up time (NIBUT), blink analysis, lipid layer assessment, and meibography – support personalised care pathways and more targeted treatment decisions. With advanced automation, high-resolution imaging, an intuitive interface, and external review software, Tera enhances clinical efficiency across a wide range of care settings – delivering both clinical insight and operational value.

Visit: topconhealthcare.com.au/products/tera

The ZEISS Atlas 500 is a state-of-the-art multi-modality solution for the anterior segment of the eye offering corneal topography and dry eye assessments. Equipped with a variety of measurement capabilities, the ZEISS Atlas 500 quickly captures relevant corneal properties with high resolution images and videos.

The compact system incorporates all assessment analysis tools into a single workstation with DICOM connectivity optimising your clinical workflow.

Placido-based measurements provide a wide range of corneal topography analysis options including elevation maps, corneal wavefront analysis, optical quality analysis, pupillometry, contact lens fitting and keratoconus screening. The ZEISS Atlas 500 also provides a comprehensive dry eye report with detailed information on a variety of parameters, including meibography, ocular redness, tear meniscus height, tear film break-up time, osmolarity input, and an onboard ocular surface disease index (OSDI) questionnaire.

Contact: ZEISS Medical info.au@zeiss.com